All lobbying filings

CRANE STRATEGIES

CRANE STRATEGIES filed a Q3 report for REGENERON PHARMACEUTICALS, INC. on November 3, 2026, reporting $50,000 in lobbying income.

Lobbying for REGENERON PHARMACEUTICALS, INC. · Biopharmaceutical development and manufacturing

All filings by CRANE STRATEGIES · Everything REGENERON PHARMACEUTICALS, INC. has reported

Filing · LD-2 quarterly report Q3 report

Reporting period

3rd Quarter 2026

July 1 - Sep 30 · Posted Nov 3, 2026

Income

$50,000

What the client paid this registrant for the period.

Client based in

New York

Official filing document

Lobbyists on this filing 1

STEVEN CRANE

Previously held: Staff assistant, Senator Barbara Mikulski

A "covered position" is a government job the lobbyist held in the 20 years before registering, which the law requires them to name. See the revolving door for former members of Congress across all filings.

Government bodies contacted 3

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

Lobbying activity 1

Budget/Appropriations

Biodefense funding

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.